ACI Pharmaceuticals began its journey in Bangladesh in 1992, building on the heritage of the internationally renowned company ICI. Since then, it has grown into one of the country's leading pharmaceutical companies, focusing on quality, innovation, and affordable healthcare. ACI became the first company in Bangladesh to receive ISO 9001 certification in 1995 and later achieved ISO 14001 environmental management certification in 2000. Today, it employs more than 5,000 people nationwide and develops medicines across a wide range of therapeutic categories. ACI offers more than 550 product variations covering over 250 molecules across nearly 100 therapeutic classes. Its portfolio includes conventional medicines and advanced formulations such as insulin, inhalers, biotechnology products, and sustained-release medicines. The company exports pharmaceutical products to 30 countries across four continents, reflecting its growing international presence. Through continued research, modern manufacturing, and strict quality standards, ACI Pharmaceuticals remains committed to improving healthcare in Bangladesh and beyond.